Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Avai Bio (AVAI) Preferred Shares (2020 - 2025)

Avai Bio's Preferred Shares history spans 5 years, with the latest figure at $10.0 million for Q1 2024.

  • On a quarterly basis, Preferred Shares rose 253064.56% to $10.0 million in Q1 2024 year-over-year; TTM through Mar 2024 was $10.0 million, a 253064.56% increase, with the full-year FY2024 number at $10.0 million, up 253064.56% from a year prior.
  • Preferred Shares hit $10.0 million in Q1 2024 for Avai Bio, up from $10000.0 in the prior quarter.
  • Over the last five years, Preferred Shares for AVAI hit a ceiling of $10.0 million in Q1 2024 and a floor of $3950.0 in Q3 2020.
  • Historically, Preferred Shares has averaged $1.5 million across 5 years, with a median of $3950.0 in 2020.
  • Biggest five-year swings in Preferred Shares: changed 0.0% in 2022 and later surged 253064.56% in 2024.
  • Tracing AVAI's Preferred Shares over 5 years: stood at $3950.0 in 2020, then changed by 0.0% to $3950.0 in 2021, then changed by 0.0% to $3950.0 in 2022, then skyrocketed by 153.16% to $10000.0 in 2023, then surged by 99900.0% to $10.0 million in 2024.
  • Business Quant data shows Preferred Shares for AVAI at $10.0 million in Q1 2024, $10000.0 in Q4 2023, and $5.0 million in Q2 2023.